The latest developments and news items regarding our portfolio stocks that you should know about. Read More
Archive
Filter
Shares of BTP “Breakthrough Tech” portfolio holding Novo Nordisk (NVO) rallied on 4/28/16. The company announced “top line” results from its global Phase 3a trial of semaglutide, noting that the medication “significantly” reduces the risk of major cardiovascular events.Semaglutide is used in the treatment of type II diabetes improving control… Read More
Shares of Meridian Biosciences (VIVO) were moving steadily higher in early trading on 4/28 after the company announced its Q2 2016 earnings of 24 cents per share and revenues of $51.3 million. Estimates were for 24 cents per share in earnings and $52.09 million in revenues for the quarter. The… Read More
Rollins (NYSE: ROL) beat revenue estimates in its quarterly earnings (for the period ending March) report released this morning, though profits were in line at 15 cents per share. Despite the good news, and its recent important acquisitions, shares held steady in early trading. This is a great opportunity to buy… Read More
New information linking Zika virus to congenital malformations in Brazil was released this weekend and could provide investors with a reason to buy virus related stocks. Read More
[from the 04/25/2016 edition of Breakthrough Tech Weekly]Nimble Storage (NYSE: NMBL), which designs and sells a flash-optimized data storage platform, has been absolutely crushed so far this year. Shares have fallen by more than 14% after a couple of disappointing quarters.The company believed its products would revolutionize the data… Read More
[from the 04/25/2016 edition of Breakthrough Tech Weekly]Nimble Storage (NYSE: NMBL), which designs and sells a flash-optimized data storage platform, has been absolutely crushed so far this year. Shares have fallen by more than 14% after a couple of disappointing quarters.The company believed its products would revolutionize the data… Read More
Last week Argos Therapeutics (ARGS) announced its COO was abruptly resigning and the company known for treating aggressive forms of cancer with immunotherapy would lay off 18 lab workers. The share price immediately plunged as a result, falling from more than $12 to below $8 in a matter of days.As… Read More
Last week Argos Therapeutics (ARGS) announced its COO was abruptly resigning and the company known for treating aggressive forms of cancer with immunotherapy would lay off 18 lab workers. The share price immediately plunged as a result, falling from more than $12 to below $8 in a matter of days.As… Read More